Gita Gopinath Warns Trump’s Tariff Plan is 'Wrong Medicine' for US Trade Deficit

Harvard economist Gita Gopinath has characterized the $901 billion US trade deficit as a condition akin to "chronically high cholesterol." Gopinath criticized Donald Trump's proposed 150-day tariff plan, labeling it the "wrong medicine" for the nation's structural economic imbalances. She warned that such aggressive trade barriers might fail to reduce the deficit while potentially triggering inflationary pressures and higher costs for consumers. Market participants are closely monitoring the potential impact on the DXY and SPY, as trade tensions typically drive heightened market volatility. Furthermore, the risk of retaliatory measures from global trading partners could significantly influence currency pairs like USD/CNY and USD/MXN. These comments highlight the growing debate among top economists regarding the long-term efficacy of protectionist trade policies.